Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Open in API
Filings indexed 1,707 across all filing types
Latest filing 2022-04-08 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Compliance Certificate under Reg.74(5) of SEBI (DP) Regulations for the quarter ended 31st March, 2022
Regulatory Filings
2022-04-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a tabular disclosure listing entities and persons categorized as promoters or promoter groups for Natco Pharma Limited, referencing Regulation 31(4) and the financial year ending 31-Mar-2022. This type of disclosure corresponds to notifications of major shareholdings or promoter holdings as per regulatory requirements. The document length is short (2586 characters) and contains no financial statements or management commentary. It is not an annual report, earnings release, or any detailed financial or governance report. The content aligns with a Major Shareholding Notification, which reports changes or status of significant share ownership levels.
2022-04-05 English
Appointment of Sri Chekuri Venkat Ramesh as Company Secretary and Compliance Officer
Regulatory Filings
2022-03-31 English
Appointment
Board/Management Information Classification · 95% confidence The document contains tables listing reasons for changes, dates of cessation and appointment, brief profiles, and disclosures of relationships between directors. The content focuses on changes in company personnel, specifically appointments and cessations of directors or senior management. There is no indication of financial data, audit information, or report announcements. The document length is short (1489 characters), and it is clearly about management changes rather than financial results or regulatory filings. Therefore, the document fits best under the category of Board/Management Information (MANG).
2022-03-31 English
Retirement of Sri Adinarayana Madineedi, Company Secretary and Vice President (Legal and Corporate Affairs)
Regulatory Filings
2022-03-31 English
Retirement
Board/Management Information Classification · 95% confidence The document contains tables listing reasons for change, dates of cessation and appointment, brief profiles, and disclosures of relationships between directors. The content focuses on changes in company personnel, specifically appointments and cessations of directors or senior management. There is no indication of financial data, report publication, or regulatory filings beyond management changes. The document length is short (1489 characters), and it does not reference any financial report or voting results. Therefore, the document is best classified as Board/Management Information (MANG).
2022-03-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.